James M Daly's Net Worth
$31.1 Million
Who is James M Daly?
James M Daly has an estimated net worth of $31.1 Million. This is based on reported shares across multiple companies, which include INCYTE CORP, MADRIGAL PHARMACEUTICALS, INC., CHIMERIX INC, HALOZYME THERAPEUTICS, INC., ACADIA PHARMACEUTICALS INC, and BELLICUM PHARMACEUTICALS, INC.
SEC CIK
James M Daly's CIK is 0001560782
Past Insider Trading and Trends
2014 was James M Daly's most active year for acquiring shares with 34 total transactions. James M Daly's most active month to acquire stocks was the month of May. 2014 was James M Daly's most active year for disposing of shares, totalling 41 transactions. James M Daly's most active month to dispose stocks was the month of March. 2024 saw James M Daly paying a total of $3,321,344.12 for 66,306 shares, this is the most they've acquired in one year. In 2014 James M Daly cashed out on 555,552 shares for a total of $17,037,138.57, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
INCYTE CORP (INCY) Snapshot price: $60.96
EVP, Chief Commercial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$64.65 | -$1,019,423.49 | 3.52K |
Scheduled
|
Jun 23
| ||
Form 4
|
—
|
0
|
$63.65 | -$1,033,908.57 | 3.52K |
Scheduled
|
May 26
| ||
Form 4
|
—
|
0
|
$71.82 | -$2,648,599.11 | 3.52K |
Scheduled
|
Apr 23
| ||
Form 4
|
—
|
0
|
$49.62 | -$723,863.46 | 3.52K |
Scheduled
|
Feb 23 - Feb 24
| ||
Form 4
|
—
|
0
|
$47.36 | -$673,594.64 | 3.52K |
Scheduled
|
Jan 23
| ||
Form 4
| +605.61% | 3.02K |
—
|
—
| 3.52K |
Jan 8
| |||
Form 4
|
—
|
0
|
$45.74 | -$637,719.93 |
0
|
Scheduled
|
Dec 23
| ||
Form 4
|
—
|
0
|
$45.57 | -$633,715.46 |
0
|
Scheduled
|
Nov 24
| ||
Form 4
|
—
|
0
|
$35.27 | -$404,939.97 |
0
|
Scheduled
|
Oct 23
| ||
Form 4
|
—
|
0
|
$32.35 | -$340,053.43 |
0
|
Scheduled
|
Sep 23
| ||
Form 4
|
—
|
0
|
$34.51 | -$387,940.14 |
0
|
Scheduled
|
Aug 25
| ||
Form 4
|
—
|
0
|
$32.80 | -$349,940.52 |
0
|
Scheduled
|
Jul 23
| ||
Form 4
|
—
|
0
|
$36.53 | -$433,218.82 |
0
|
Scheduled
|
Jun 23
| ||
Form 4
|
—
|
0
|
$32.77 | -$349,273.86 |
0
|
Scheduled
|
May 23
| ||
Form 4
|
—
|
0
|
$32.32 | -$940,511.45 |
0
|
Scheduled
|
Apr 23
| ||
Form 4
|
—
|
0
|
$41.74 | -$7,839,300.87 |
0
|
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MADRIGAL PHARMACEUTICALS, INC. (MDGL) Snapshot price: $243.89
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +59.60% | 714 |
—
|
—
| 1.91K |
Jun 25
| |||
Form 4
|
—
|
0
|
$177.60 | -$4,897,286.20 | 1.2K |
Scheduled
|
Apr 1 - Apr 2
| ||
Form 4
|
∞
| 1.2K |
—
|
—
| 1.2K |
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CHIMERIX INC (CMRX) Snapshot price: $0.8503
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HALOZYME THERAPEUTICS, INC. (HALO) Snapshot price: $59.21
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -49.38% | -20.00K |
$43.73 | -$874,520.00 | 20.5K |
Aug 11 - Aug 14
| |||
Form 4
| +24.86% | 8.06K |
—
|
—
| 40.5K |
May 5
| |||
Form 4
| +23.66% | 6.21K |
—
|
—
| 32.44K |
May 5
| |||
Form 4
| +24.90% | 5.23K |
—
|
—
| 26.23K |
May 5
| |||
Form 4
| -33.04% | -10.36K |
$40.41 | -$418,799.92 | 21K |
Nov 25
| |||
Form 4
| -52.26% | -34.34K |
$29.12 | -$999,893.44 | 31.36K |
Aug 13
| |||
Form 4
| +15.52% | 8.83K |
—
|
—
| 65.7K |
Apr 30
| |||
Form 4
| +27.23% | 12.17K |
—
|
—
| 56.87K |
May 2
| |||
Form 4
| +30.18% | 10.36K |
—
|
—
| 44.7K |
May 2
| |||
Form 4
| +69.97% | 14.13K |
—
|
—
| 34.34K |
May 4
| |||
Form 4
|
∞
| 20.2K |
—
|
—
| 20.2K |
May 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACADIA PHARMACEUTICALS INC (ACAD) Snapshot price: $16.07
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +36.95% | 6.65K |
—
|
—
| 24.65K |
May 29
| |||
Form 4
|
∞
| 18K |
—
|
—
| 18K |
Jun 22 - Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
$38.76 | -$649,478.25 |
0
|
May 11
| |||
Form 4
|
—
|
0
|
$27.66 | -$608,260.08 |
0
|
Sep 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||